Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours (2021) Dawod M, Gordoa TA, Cives M, De Mestier L, Crona J, Spada F, Oberg K, et al. Journal article, Review article Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study (2021) Tittel SR, Laubner K, Schmid SM, Kress S, Merger S, Karges W, Wosch FJ, et al. Journal article Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease (2021) Drobny A, Ngo PA, Neurath M, Zunke F, Lopez-Posadas R Journal article, Review article Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy (2021) Bojarski C, Waldner M, Rath T, Schürmann S, Neurath M, Atreya R, Siegmund B Journal article, Review article Physical phenotype of blood cells is altered in COVID-19 (2021) Kubankova M, Hohberger B, Hoffmanns J, Fürst J, Herrmann M, Guck J, Kraeter M Journal article Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning (2021) Jakob CEM, Mahajan UM, Oswald M, Stecher M, Schons M, Mayerle J, Rieg S, et al. Journal article Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2021) Hohberger B, Ganslmayer M, Lucio M, Kruse F, Hoffmanns J, Moritz M, Rogge L, et al. Journal article E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis (2021) Patankar J, Muller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, et al. Journal article The potential of omics technologies for the treatment of immune‐mediated inflammatory diseases (2021) Anchang CG, Xu C, Raimondo MG, Atreya R, Maier A, Schett G, Zaburdaev V, et al. Journal article, Review article Target heterogeneity in oncology: The best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer (2021) Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel ME, Eberhardt N, Zengerling F, et al. Journal article, Review article